The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
22 Apr 2020
NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cel...
Dr Yann-Alexandre Vano - Hôpital Européen Georges-Pompidou, Paris, France
18 Feb 2020
Surgical treatment of cholangiocarcinoma and liver metastases
Dr. Amit Mathur, Mayo Clinic, Rochester, USA
21 Oct 2019
Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA
4 Oct 2019
CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line...
Dr Thomas Yau - The University of Hong Kong, Hong Kong
4 Oct 2019
Health-related quality of life for patients with metastatic pancreatic cancer: U...
Prof Eric Van Cutsem and Dr Teresa Macarulla
2 Oct 2019
Key developments in pancreatic cancer from ESMO 2019
Prof Eileen O'Reilly and Dr Ian Chau
2 Oct 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Dr Parag Parikh - Mayo Clinic, Rochester, USA
17 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
24 Jun 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
